Pancreatic Cancer Research

ResearcherCentral South UniversityActive in the last 2 years

Jun He

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-5309-0765; OpenAlex author ID A5101420271. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2020: 1 paper · 2021: 2 papers · 2022: none · 2023: none · 2024: 1 paper

Papers 4

  1. Systematic analysis of TREM2 and its carcinogenesis in pancreatic cancer. Co-author DOI 10.21037/tcr-24-201↗
  2. HELLS, a chromatin remodeler is highly expressed in pancreatic cancer and downregulation of it impairs tumor growth and sensitizes to cisplatin by reexpressing… Last author DOI 10.1002/cam4.3627↗
  3. KDM1A and KDM3A promote tumor growth by upregulating cell cycle-associated genes in pancreatic cancer. Co-author DOI 10.1177/15353702211023473↗
  4. Downregulation of METTL14 increases apoptosis and autophagy induced by cisplatin in pancreatic cancer cells. Co-author DOI 10.1016/j.biocel.2020.105731↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xuyang Hou · 3 shared papers, 2020–2021 · strength 0.41
  2. Leping Yang · 3 shared papers, 2020–2021 · strength 0.41
  3. Yan Zhou · 2 shared papers, 2020–2021 · strength 0.26
  4. Fanhua Kong · 2 shared papers, 2020–2021 · strength 0.26
  5. Wanting Zheng · 1 shared paper, 2024 · strength 0.23
  6. Qin L · 1 shared paper, 2024 · strength 0.23
  7. Daming Li · 1 shared paper, 2021 · strength 0.15
  8. Kunpeng Wang · 1 shared paper, 2021 · strength 0.14
  9. Xiongying Miao · 1 shared paper, 2020 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.